• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过质谱法对生物制药糖基化进行分析检测与表征。

Analytical detection and characterization of biopharmaceutical glycosylation by MS.

作者信息

Oh Myung Jin, Hua Serenus, Kim Unyong, Kim Hyun Joong, Lee Jua, Kim Jae-Han, An Hyun Joo

机构信息

Graduate School of Analytical Science & Technology, Chungnam National University, Daejeon, Korea.

Asia Glycomics Reference Site, Daejeon, Korea.

出版信息

Bioanalysis. 2016 Apr;8(7):711-27. doi: 10.4155/bio.16.20. Epub 2016 Mar 11.

DOI:10.4155/bio.16.20
PMID:26964748
Abstract

Glycosylation plays an important role in ensuring the proper structure and function of most biotherapeutic proteins. Even small changes in glycan composition, structure, or location can have a drastic impact on drug safety and efficacy. Recently, glycosylation has become the subject of increased focus as biopharmaceutical companies rush to create not only biosimilars, but also biobetters based on existing biotherapeutic proteins. Against this backdrop of ongoing biopharmaceutical innovation, updated methods for accurate and detailed analysis of protein glycosylation are critical for biopharmaceutical companies and government regulatory agencies alike. This review summarizes current methods of characterizing biopharmaceutical glycosylation, including compositional mass profiling, isomer-specific profiling and structural elucidation by MS and hyphenated techniques.

摘要

糖基化在确保大多数生物治疗蛋白的正确结构和功能方面发挥着重要作用。即使聚糖组成、结构或位置的微小变化也会对药物安全性和疗效产生巨大影响。近年来,随着生物制药公司不仅急于生产生物仿制药,还基于现有的生物治疗蛋白开发更优生物药,糖基化已成为越来越受关注的主题。在这种持续的生物制药创新背景下,更新后的准确详细分析蛋白质糖基化的方法对生物制药公司和政府监管机构都至关重要。本综述总结了目前表征生物制药糖基化的方法,包括组成性质量分析、异构体特异性分析以及通过质谱和联用技术进行结构解析。

相似文献

1
Analytical detection and characterization of biopharmaceutical glycosylation by MS.通过质谱法对生物制药糖基化进行分析检测与表征。
Bioanalysis. 2016 Apr;8(7):711-27. doi: 10.4155/bio.16.20. Epub 2016 Mar 11.
2
Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS.通过质谱对重组促红细胞生成素生物治疗药物和生物类似药进行糖组学表征的分析平台。
Bioanalysis. 2013 Mar;5(5):545-59. doi: 10.4155/bio.12.327.
3
Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.通过液相色谱-质谱联用对CTLA4-Ig融合蛋白中糖基化修饰进行多方面表征
MAbs. 2014;6(6):1474-85. doi: 10.4161/mabs.36313.
4
Current landscape of protein glycosylation analysis and recent progress toward a novel paradigm of glycoscience research.蛋白质糖基化分析的现状以及糖科学研究新范式的最新进展。
J Pharm Biomed Anal. 2016 Oct 25;130:273-300. doi: 10.1016/j.jpba.2016.07.015. Epub 2016 Jul 17.
5
Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications.生物类似药的糖基化:分析表征的最新进展及其临床意义。
Anal Chim Acta. 2019 Dec 16;1089:1-18. doi: 10.1016/j.aca.2019.08.044. Epub 2019 Aug 22.
6
Physicochemical Characterization, Glycosylation Pattern and Biosimilarity Assessment of the Fusion Protein Etanercept.依那西普融合蛋白的理化特性、糖基化模式与生物相似性评估。
Protein J. 2018 Apr;37(2):164-179. doi: 10.1007/s10930-018-9757-y.
7
Expanding the structural resolution of glycosylation microheterogeneity in therapeutic proteins by salt-free hydrophilic interaction liquid chromatography tandem mass spectrometry.通过无盐亲水相互作用液相色谱串联质谱法扩展治疗性蛋白质中糖基化微异质性的结构分辨率。
MAbs. 2024 Jan-Dec;16(1):2395503. doi: 10.1080/19420862.2024.2395503. Epub 2024 Aug 27.
8
Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis.亲水作用色谱-质谱联用:一种强大的分析工具,可用于在分析的中程水平上比较原创药和生物类似药治疗性单克隆抗体。
Anal Chem. 2017 Feb 7;89(3):2086-2092. doi: 10.1021/acs.analchem.6b04726. Epub 2017 Jan 25.
9
N-glycan Analysis in Molecular Medicine: Innovator and Biosimilar Protein Therapeutics.分子医学中的 N-糖链分析:创新型和生物类似物蛋白治疗药物。
Curr Mol Med. 2020;20(10):828-839. doi: 10.2174/1566524020999201203212352.
10
Discrepancies between High-Resolution Native and Glycopeptide-Centric Mass Spectrometric Approaches: A Case Study into the Glycosylation of Erythropoietin Variants.高分辨率天然肽段和糖肽靶向质谱分析方法的差异:以红细胞生成素变体糖基化分析为例
J Am Soc Mass Spectrom. 2021 Aug 4;32(8):2099-2104. doi: 10.1021/jasms.1c00060. Epub 2021 Apr 15.

引用本文的文献

1
Glycomics studies using sialic acid derivatization and mass spectrometry.使用唾液酸衍生化和质谱法的糖组学研究。
Nat Rev Chem. 2020 May;4(5):229-242. doi: 10.1038/s41570-020-0174-3. Epub 2020 Mar 17.
2
Capillary Electrophoresis-Based N-Glycosylation Analysis in the Biomedical and Biopharmaceutical Fields.基于毛细管电泳的生物医学和生物制药领域的 N-糖基化分析。
Adv Exp Med Biol. 2021;1336:129-137. doi: 10.1007/978-3-030-77252-9_7.
3
In-Depth Glycan Characterization of Therapeutic Glycoproteins by Stepwise PGC SPE and LC-MS/MS.
分步 PGC SPE 和 LC-MS/MS 对治疗性糖蛋白的深入聚糖表征。
Methods Mol Biol. 2021;2271:121-131. doi: 10.1007/978-1-0716-1241-5_9.
4
Discrepancies between High-Resolution Native and Glycopeptide-Centric Mass Spectrometric Approaches: A Case Study into the Glycosylation of Erythropoietin Variants.高分辨率天然肽段和糖肽靶向质谱分析方法的差异:以红细胞生成素变体糖基化分析为例
J Am Soc Mass Spectrom. 2021 Aug 4;32(8):2099-2104. doi: 10.1021/jasms.1c00060. Epub 2021 Apr 15.
5
Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency.基于结构的干扰素λ4糖基工程增强其产量和抗病毒效力。
Cytokine. 2020 Jan;125:154833. doi: 10.1016/j.cyto.2019.154833. Epub 2019 Aug 31.